Immunai: acquisition of Nebion
Biotech company Immunai has acquired Nebion, a bioinformatics firm. Additionally, Immunai has made a number of executive appointments, including Jacques Banchereau as chief sience officer, and Mark Jacobstein as chief business officer.
“As with other machine learning endeavors like autonomous driving or NLP, having the right data is key,” said Noam Solomon, Immunai CEO and co-founder. “We’re thrilled to bring on the Nebion team and their platform to enhance our target discovery and validation capabilities.”
